Reconstitution Solution (30ml) (commonly designated in clinical, laboratory, and consumer settings as Bacteriostatic Water for Injection, BAC Water, or BWFI) is a sterile, non-pyrogenic aqueous pharmaceutical preparation formulated exclusively as a multi-dose diluent vehicle for the reconstitution and dilution of parenteral powders, peptide hormones, and lyophilized drugs. Chemically, the preparation comprises:<\/p>\n
Solvent:<\/b> Purified Water for Injections (BP\/EP\/USP), meeting standard pharmacopoeial specifications for endotoxin limits ($<0.25\\text{ EU\/mL}$<\/span>), conductivity, and total organic carbon.<\/p>\n<\/li>\n Antimicrobial Preservative:<\/b> Benzyl alcohol ($\\text{C}_7\\text{H}_8\\text{O}$<\/span> or phenylmethanol) at a standardized mass-volume concentration of $0.9\\%\\text{ w\/v}$<\/span> ($9\\text{ mg\/mL}$<\/span>).<\/p>\n<\/li>\n Osmolarity and Tonicity:<\/b> The formulation is distinctly hypotonic, exhibiting an approximate calculated osmolarity of $83\\text{ mOsmol\/L}$<\/span> (derived primarily from the dissolved benzyl alcohol, with zero added sodium chloride or osmotic electrolytes) and a regulated pH range between 4.5 and 7.0.<\/p>\n<\/li>\n<\/ul>\n The preparation is presented in a multi-dose, $30\\text{ mL}$<\/span> clear Type I borosilicate glass vial or USP Type I polymeric container sealed with a chlorobutyl or bromobutyl rubber elastomer septum and an aluminium crimp-top flip-off tear seal.<\/p>\n Within the United Kingdom regulatory framework, bacteriostatic water preparations occupy a precise legal and clinical boundary. Authentic, licensed Bacteriostatic Water for Injection holds status as a Prescription Only Medicine (POM) under the Human Medicines Regulations 2012 when authorized with a formal Marketing Authorisation (MA) from the Medicines and Healthcare products Regulatory Agency (MHRA). It is not listed as a standard open-access General Sales List (GSL) or Pharmacy (P) retail line, as multi-dose diluents containing antimicrobial preservatives require professional oversight to prevent dangerous administration routes (e.g., intrathecal toxicity). Crucially, the overwhelming majority of $30\\text{ mL}$<\/span> BAC water vials circulating within domestic bodybuilding, private aesthetic, and online peptide communities represent unlicensed medical devices or unregulated chemicals imported from overseas or compounded by underground laboratories (UGLs) without MHRA marketing authorisation. These illicit preparations present severe clinical hazards, including inaccurate benzyl alcohol concentrations, particulate contamination, unverified sterility, alkaline glass leaching, and sub-potent antimicrobial preservation.<\/p>\n As an inert pharmaceutical solvent and diluent vehicle, bacteriostatic water possesses no intrinsic primary receptor-mediated therapeutic pharmacodynamic properties. Its entire functional pharmacology is governed by the biophysical and antimicrobial properties of its constituent preservative, benzyl alcohol:<\/p>\n Bacteriostatic Membrane Disruption:<\/b> Benzyl alcohol acts as a low-molecular-weight amphiphilic aromatic alcohol. At the standard $0.9\\%\\text{ w\/v}$<\/span> concentration, it partitions into the hydrophobic core of microbial cell membranes (targeting vegetative bacterial and fungal contaminants inadvertently introduced during repeated percutaneous needle punctures of the multi-dose vial). The insertion of phenyl rings disrupts fatty acyl chain packing, reduces lipid bilayer order, and increases membrane fluidity. This results in the formation of transient membrane pores, loss of the proton-motive force, leakage of essential intracellular cations ($K^+$<\/span>, $Mg^{2+}$<\/span>), and cessation of metabolic respiration, arresting cellular division (bacteriostasis).<\/p>\n<\/li>\n Spectrum of Activity:<\/b> Under optimal compounding conditions, $0.9\\%$<\/span> benzyl alcohol exhibits bacteriostatic and bactericidal efficacy against common cutaneous, environmental, and opportunistic pathogens, including Staphylococcus aureus<\/i>, Escherichia coli<\/i>, Pseudomonas aeruginosa<\/i>, y Candida albicans<\/i>, maintaining microbial stability for up to 28 days post-puncture when stored correctly.<\/p>\n<\/li>\n Absence of Intrinsic Cytoprotective or Anabolic Action:<\/b> The diluent does not stabilize, bind to, or activate mammalian peptide receptors, glucocorticoid receptors, or androgen receptors. Its sole physiological interaction in vivo relates to the transient local sensory response upon injection and systemic hepatic biotransformation of the cleared preservative.<\/p>\n<\/li>\n<\/ul>\n Bacteriostatic Water for Injection containing $0.9\\%$<\/span> benzyl alcohol possesses no independent therapeutic or restorative clinical indications in the United Kingdom. Its approved medical use is strictly defined as an auxiliary pharmaceutical diluent:<\/p>\n Reconstitution and Dilution of Compatible Parenteral Medications:<\/b> Officially indicated for dissolving or diluting compatible lyophilized drugs, diagnostic substances, and peptide hormones intended for repeated multi-dose withdrawal via sterile technique, strictly via:<\/p>\n Intramuscular (IM) injection.<\/b><\/p>\n<\/li>\n Subcutaneous (SC) injection.<\/b><\/p>\n<\/li>\n Intravenous (IV) injection<\/b> (strictly confined to small-volume, single-dose admixtures where compatibility has been clinically validated).<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n The National Institute for Health and Care Excellence (NICE) does not maintain independent clinical guidance for bacteriostatic water; rather, its usage conforms to overarching British Pharmacopoeia (BP) and MHRA standards for sterile compounding and parenteral administration. In authorized NHS secondary care environments, the use of preservative-containing diluents has been largely phased out in favor of single-use ampoules of preservative-free Water for Injections BP or $0.9\\%$<\/span> Sodium Chloride BP, specifically to eliminate the risk of accidental administration to neonates or via neuroaxial routes.<\/p>\n The non-approved, unregulated application of $30\\text{ mL}$<\/span> BAC Water is extensive within illicit athletic bodybuilding, unlicensed hormone\/peptide self-administration networks, and underground “biohacking” circles. In these unregulated sectors, it is utilized as the primary vehicle for reconstituting:<\/p>\n Lyophilized anabolic and metabolic peptides (e.g., retatrutide, tirzepatide, semaglutide, sermorelin, BPC-157, TB-500, CJC-1295).<\/p>\n<\/li>\n Unlicensed growth hormone (somatropin) and human chorionic gonadotrophin (hCG) multi-dose regimens.<\/p>\n<\/li>\n<\/ul>\n BAC Water holds no independent status within the NHS drug tariff as a consumer health item, cannot be supplied without an authorized prescription, and must never be employed as an intravenous hydration fluid.<\/p>\n Because bacteriostatic water functions as a solvent carrier, its in vivo pharmacokinetic disposition is dictated by the systemic clearance, distribution, and biotransformation of its constituent solute, benzyl alcohol, and the aqueous dispersion of the co-administered drug:<\/p>\n Absorption and Distribution:<\/b> Following subcutaneous or intramuscular injection, the aqueous solvent rapidly equilibrates with extracellular fluid through Starling forces and capillary filtration. Dissolved benzyl alcohol is rapidly and completely absorbed across local microvascular capillary beds into systemic circulation. It exhibits an extensive volume of distribution ($V_d$<\/span>), readily crossing physiological membranes, the placental barrier, and the blood-brain barrier (BBB).<\/p>\n<\/li>\n Biotransformation (Hepatic Oxidation):<\/b> Systemic benzyl alcohol undergoes rapid, extensive hepatic clearance via enzymatic oxidation. In healthy adults possessing mature hepatic enzyme systems, benzyl alcohol is oxidized by cytoplasmic alcohol dehydrogenase (ADH) into benzaldehyde. Benzaldehyde is rapidly converted by aldehyde dehydrogenase (ALDH) into benzoic acid. Benzoic acid is subsequently conjugated with endogenous glycine via mitochondrial glycine N-acyltransferase within the liver and renal cortex to yield hippuric acid ($N\\text{-benzoylglycine}$<\/span>).<\/p>\n<\/li>\n Elimination:<\/b> Hippuric acid, alongside trace unconjugated benzoic acid glucuronides, is eliminated rapidly via renal glomerular filtration and active proximal tubular secretion into urine. In healthy human adults, more than $80\\text{ to }90\\%$<\/span> of an absorbed therapeutic dose of benzyl alcohol is eliminated as urinary hippuric acid within 6 hours. The biological elimination half-life ($t_{1\/2}$<\/span>) of trace benzyl alcohol in adults is rapid (typically under 60 minutes). However, in individuals with severe hepatic cirrhosis or immature neonatal metabolic systems, enzymatic capacity is readily saturated, leading to catastrophic toxic accumulation.<\/p>\n<\/li>\n<\/ul>\n When administered appropriately in minimal volumes ($0.5\\text{ to }2\\text{ mL}$<\/span>) as a vehicle for subcutaneous or intramuscular medications, bacteriostatic water is generally well tolerated systemically, though it causes predictable local tissue effects. However, misuse, excessive volume administration, or contra-indicated routes induce severe, potentially fatal toxicities:<\/p>\n Common Local Reactions ($1\/100$<\/span> to $<1\/10$<\/span>):<\/b><\/p>\n Local injection-site burning, stinging, or transient pain immediately following subcutaneous deposition (benzyl alcohol transiently depolarizes nociceptive C-fibres in the dermis).<\/p>\n<\/li>\n Localized injection-site erythema, mild induration, and tenderness.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n Haematological Toxicity (Intravenous High-Volume Ingestion):<\/b><\/p>\n Severe intravascular haemolysis: Because BAC water is hypotonic ($83\\text{ mOsmol\/L}$<\/span>) and lacks sodium chloride, direct intravenous injection of large boluses causes rapid osmotic water influx into erythrocytes, leading to swelling, cell rupture, haemoglobinaemia, haemoglobinuria, and secondary pigment-induced acute tubular necrosis (ATN).<\/p>\n<\/li>\n<\/ul>\n<\/li>\n Fatal Neuroaxial Toxicity (Absolute Hazard):<\/b><\/p>\n Intrathecal, epidural, or neural injection results in severe, irreversible neurotoxicity. Benzyl alcohol induces rapid demyelination, direct axonal lysis, sterile chemical arachnoiditis, flaccid paraplegia, and fatal brainstem encephalitis.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n Paediatric and Neonatal “Gasping Syndrome”:<\/b><\/p>\n Benzyl alcohol toxicity in neonates and low-birth-weight infants: Immature neonatal hepatic alcohol and aldehyde dehydrogenase pathways cannot metabolize benzoic acid. Toxic accumulation leads to severe metabolic acidosis, central nervous system depression, hypotonia, cardiovascular collapse, gasping respirations, convulsions, intraventricular haemorrhage, and death.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n Contamination Hazards of Unregulated $30\\text{ mL}$<\/span> Vials:<\/b><\/p>\n Multiple needle punctures through non-medical grade septa over extended periods (often exceeding the 28-day validated limit) introduce environmental bacterial pathogens (Serratia marcescens<\/i>, Burkholderia cepacia<\/i>). Self-injection of non-sterile, contaminated solution produces severe subcutaneous abscesses, necrotizing cellulitis, bacterial myositis, and life-threatening systemic sepsis.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n Given its unique toxicological and chemical properties, the handling, prescribing, and administration of Bacteriostatic Water for Injection requires strict adherence to mandatory clinical precautions:<\/p>\n Contraindications:<\/b><\/p>\n Absolute Contraindication in Neonates, Premature Infants, and Paediatric Patients under 3 Years:<\/b> Complete, mandatory contraindication due to fatal neonatal gasping syndrome and metabolic acidosis.<\/p>\n<\/li>\n Absolute Contraindication for Neuroaxial Administration:<\/b> Strictly prohibited from intrathecal, epidural, subarachnoid, retrobulbar, or intraocular administration.<\/p>\n<\/li>\n Documented Hypersensitivity:<\/b> Absolute contraindication in individuals with known Type I (anaphylactic) or Type IV (contact dermatitis) hypersensitivity to benzyl alcohol or benzoic acid.<\/p>\n<\/li>\n Direct Large-Volume Intravenous Infusion:<\/b> Prohibited from use as an intravenous fluid replenishment source; must never be infused without adding sufficient osmotic solutes to achieve isotonicity ($\\sim 280\\text{ to }300\\text{ mOsmol\/L}$<\/span>).<\/p>\n<\/li>\n<\/ul>\n<\/li>\n Drug Interactions:<\/b><\/p>\n Therapeutic Protein and Monoclonal Antibody Inactivation:<\/i> Benzyl alcohol alters the tertiary structure and promotes aggregation of high-molecular-weight proteins. Monoclonal antibodies, vaccines, and specific large-chain biological therapies must never be reconstituted with BAC water unless explicitly authorized in the manufacturer’s summary of product characteristics (SmPC).<\/p>\n<\/li>\n Narrow-Therapeutic-Index Lyophilized Drugs:<\/i> Reconstitution must strictly adhere to the manufacturer-validated diluent; altering the solvent from sterile $0.9\\%$<\/span> saline to BAC water can alter precipitation kinetics and bioavailability.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n Clinical Precautions and Harm Minimisation:<\/b><\/p>\n Strict Multi-Dose Expiry Rule (28-Day Limit): Once the rubber septum of a $30\\text{ mL}$<\/span> bacteriostatic water vial is punctured, the vial must be clearly labeled with the date of entry, stored strictly under refrigeration ($2\\text{ to }8^\\circ\\text{C}$<\/span>) or controlled room temperature ($<25^\\circ\\text{C}$<\/span>), and discarded after 28 days.<\/p>\n<\/li>\n Aseptic Technique Verification: Every puncture must be preceded by aggressive friction-disinfection of the rubber elastomeric stopper using a single-use $70\\%$<\/span> isopropyl alcohol wipe allowed to dry fully for 30 seconds.<\/p>\n<\/li>\n Toxicity and Sepsis Red Flags: Patients presenting with spreading circumferential erythema, localized fluctuance, intense purulent discharge, high-grade pyrexia ($>38.0^\\circ\\text{C}$<\/span>), systemic rigors, or unexplained severe metabolic acidosis following self-injection of reconstituted research compounds require immediate emergency (999\/A&E) transfer for broad-spectrum intravenous antimicrobial therapy and surgical evaluation.<\/p>\n<\/li>\n Unregulated Product Counseling: Clinicians encountering individuals sourcing unverified $30\\text{ mL}$<\/span> BAC water from online or grey-market peptide vendors should actively warn them of the risks of chemical non-sterility and heavy metal contamination, advising that unregulated diluents represent a primary etiology of severe soft-tissue abscesses in illicit self-administration cohorts.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n 2. Mechanism of Action and Pharmacodynamics<\/h2>\n
\n
3. Approved UK Clinical Indications and Therapeutic Scope<\/h2>\n
\n
\n
\n
4. Pharmacokinetic Profile and Metabolic Fate<\/h2>\n
\n
5. Physiological Effects and Adverse Event Spectrum<\/h2>\n
\n
\n
\n
\n
\n
\n
6. Contraindications, Drug Interactions, and Clinical Precautions<\/h2>\n
\n
\n
\n
\n